SMTL ID : 4jwr.3 (2 other biounits)

Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

monomer

Ligands

1 x 1MY: {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid(Non-covalent)

1MY.1: 10 residues within 4Å: Chain A: L.38, L.41, G.42, I.45, M.46, F.70, V.77, H.80, I.83, Y.84 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.45 Salt bridges: A:H.80 pi-Stacking: A:H.80 Halogen bonds: A:H.80

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gonzalez-Lopez de Turiso, F. et al., Rational Design and Binding Mode Duality of MDM2-p53 Inhibitors. J.Med.Chem. (2013)

Release Date

2013-05-01

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence